Julian Baker Insider Profile
4 Followers
Julian Baker, Director, Ten Percent Owner at Incyte, holds 20.42M shares in Incyte (Ticker: INCY), holds 78.89K shares in Aceragen (Ticker: ACGN), holds 9.44M shares in Synageva (Ticker: GEVA).
Julian Baker's Trading History
| INCYIncyte | Feb 22, 2017 | Director, Ten Percent Owner | Uninformative Buy | ― | $2.47B | |
| ACGNAceragen | Jan 05, 2017 | ― | Uninformative Buy | 63.76K | $29.98K | |
| GEVASynageva | Jun 22, 2015 | ― | Uninformative Buy | ― | ― | |
| XOMAXOMA Royalty Corporation | Oct 31, 2012 | ― | Informative Buy | 14.17M | $19.31M | |
| GHDXGenomic Health | May 23, 2012 | ― | Informative Buy | 5.40M | $145.33M | |
| INVAInnoviva | ― | Director | ― | $643.96K |
You May Also Like
Julian Baker insider profile FAQ
What is the percentage of profitable transactions made by Julian Baker?
The percentage of profitable transactions made by Julian Baker is 60%.
What is the average return per transaction made by Julian Baker?
The average return per transaction made by Julian Baker is 35.80%.
What stocks does Julian Baker hold?
Julian Baker holds: INCY, ACGN, GEVA, GHDX, XOMA, INVA stocks.
What was Julian Baker's most profitable transaction?
Julian Baker’s most profitable transaction was an Informative Buy of INCY stock on March 17, 2016. The return on the trade was 134.60%.
What is Julian Baker's role in Incyte?
Julian Baker's role in Incyte is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
